WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
13th Nov 2006, 15:57 GMT
Study Published in Current Medical Research and Opinion(R) Shows Combination Therapy Provides Mean LDL-C Drops of 32%
WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions related news:
- WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions — ArriveNet : Health
- Daiichi Sankyo, Inc.: WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions — Market Wire - Pharmaceuticals and Biotech
- Daiichi Sankyo, Inc.: First Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect on LDL-C Finds Additional Lipid Parameter Benefits — Market Wire - Pharmaceuticals and Biotech
- 1st Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect on LDL-C Finds Additional Lipid Parameter Benefits — StratWire - Business of Healthcare NewsFeed
- First Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect on LDL-C Finds Additional Lipid Parameter Benefits — ArriveNet : Press Releases
- Combination Therapy More Effective for Overactive Bladder — RedOrbit News - Health
- Combination therapy appears more effective than single drug for lower urinary tract symptoms — EurekAlert! - Medicine and Health
- SSRI Plus Cognitive Behavioral Therapy Effective for Pathological Gambling — Medscape Psychiatry Headlines
- Elsewhere — In the Pipeline
- Volume 194, number 12: Treatment Benefit on Cerebrospinal Fluid HIV-1 Levels in the Setting of Systemic Virological Suppression and Failure — J Infect Dis Latest Issue
Latest news from Cardiology News from StratCenter.com:
- Merck says new drug is safer than Vioxx
- Volcano Announces Clinical Review of Key Presentations From TCT 2006
- Most defibrillators buried with patients: study
- Esaote Harnesses TX Instruments DSPs to Deliver Next-Generation Medical Diagnostic Systems
- Cerenis Therapeutics Closes $53.5 mln Financing
- November 14th is World Diabetes Day
- Misonix to Conduct Q1 FYE 2007 Financial Results Conference Call and Web Cast
- Clinical Data and Diagene in Cardiac Channelopathy Test Distribution Agreement for Germany, Switzerland and Austria
- Study Provides Further Support for Cardiovascular Safety of OTC Doses of Naproxen Sodium
- National US Program Gets Americans Dancing for Heart Health